296 related articles for article (PubMed ID: 24569476)
1. Structural basis for the prion-like MAVS filaments in antiviral innate immunity.
Xu H; He X; Zheng H; Huang LJ; Hou F; Yu Z; de la Cruz MJ; Borkowski B; Zhang X; Chen ZJ; Jiang QX
Elife; 2014 Jan; 3():e01489. PubMed ID: 24569476
[TBL] [Abstract][Full Text] [Related]
2. Three-stranded antiviral attack.
Patel JR; García-Sastre A
Elife; 2014 Jan; 3():e02369. PubMed ID: 24596154
[TBL] [Abstract][Full Text] [Related]
3. Solid-state NMR resonance assignments of the filament-forming CARD domain of the innate immunity signaling protein MAVS.
He L; Lührs T; Ritter C
Biomol NMR Assign; 2015 Oct; 9(2):223-7. PubMed ID: 25301530
[TBL] [Abstract][Full Text] [Related]
4. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.
Shi Z; Zhang Z; Zhang Z; Wang Y; Li C; Wang X; He F; Sun L; Jiao S; Shi W; Zhou Z
J Biol Chem; 2015 Oct; 290(44):26811-20. PubMed ID: 26385923
[TBL] [Abstract][Full Text] [Related]
5. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades.
Liu S; Chen J; Cai X; Wu J; Chen X; Wu YT; Sun L; Chen ZJ
Elife; 2013 Aug; 2():e00785. PubMed ID: 23951545
[TBL] [Abstract][Full Text] [Related]
6. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.
Tang ED; Wang CY
PLoS One; 2010 Feb; 5(2):e9172. PubMed ID: 20161788
[TBL] [Abstract][Full Text] [Related]
7. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.
Hou F; Sun L; Zheng H; Skaug B; Jiang QX; Chen ZJ
Cell; 2011 Aug; 146(3):448-61. PubMed ID: 21782231
[TBL] [Abstract][Full Text] [Related]
8. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.
Paz S; Vilasco M; Werden SJ; Arguello M; Joseph-Pillai D; Zhao T; Nguyen TL; Sun Q; Meurs EF; Lin R; Hiscott J
Cell Res; 2011 Jun; 21(6):895-910. PubMed ID: 21200404
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization.
Nobre L; Wise D; Ron D; Volmer R
PLoS One; 2015; 10(8):e0136883. PubMed ID: 26317833
[TBL] [Abstract][Full Text] [Related]
10. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.
Wang R; Zhu Y; Lin X; Ren C; Zhao J; Wang F; Gao X; Xiao R; Zhao L; Chen H; Jin M; Ma W; Zhou H
Autophagy; 2019 Jul; 15(7):1163-1181. PubMed ID: 30741586
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of MAVS regulation at the mitochondrial membrane.
Jacobs JL; Coyne CB
J Mol Biol; 2013 Dec; 425(24):5009-19. PubMed ID: 24120683
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.
Seth RB; Sun L; Ea CK; Chen ZJ
Cell; 2005 Sep; 122(5):669-82. PubMed ID: 16125763
[TBL] [Abstract][Full Text] [Related]
13. Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.
Zamorano Cuervo N; Osseman Q; Grandvaux N
Viruses; 2018 Jan; 10(2):. PubMed ID: 29385716
[TBL] [Abstract][Full Text] [Related]
14. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
15. Multiple truncated isoforms of MAVS prevent its spontaneous aggregation in antiviral innate immune signalling.
Qi N; Shi Y; Zhang R; Zhu W; Yuan B; Li X; Wang C; Zhang X; Hou F
Nat Commun; 2017 Jun; 8():15676. PubMed ID: 28607490
[TBL] [Abstract][Full Text] [Related]
16. TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity.
Zhu W; Li J; Zhang R; Cai Y; Wang C; Qi S; Chen S; Liang X; Qi N; Hou F
EMBO J; 2019 Sep; 38(18):e102075. PubMed ID: 31390091
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain.
Potter JA; Randall RE; Taylor GL
BMC Struct Biol; 2008 Feb; 8():11. PubMed ID: 18307765
[TBL] [Abstract][Full Text] [Related]
18.
Seo J; Park YS; Kweon TH; Kang J; Son S; Kim HB; Seo YR; Kang MJ; Yi EC; Lee YH; Kim JH; Park B; Yang WH; Cho JW
Front Immunol; 2020; 11():589259. PubMed ID: 33603735
[TBL] [Abstract][Full Text] [Related]
19. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity.
Park S; Juliana C; Hong S; Datta P; Hwang I; Fernandes-Alnemri T; Yu JW; Alnemri ES
J Immunol; 2013 Oct; 191(8):4358-66. PubMed ID: 24048902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
